Arioneo has introduced an AI-powered ECG analysis system capable of detecting cardiac rhythm abnormalities, including atrial fibrillation, in racehorses during training, racing, and rest. The ...

At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...

Following its successful contribution to the American Association of Equine Practitioners-led project focused on locomotion ...

Implicity, a leader in remote patient monitoring and cardiac data management solutions, today revealed new research presented at the 2026 European Heart Rhythm Association Congress (EHRA) examining ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI(TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

CAMBRIDGE, Mass., April 08, 2026--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac ...

The latest science coming out of ACC.25, held March 29-31 in Chicago, IL, illuminated new approaches in how artificial intelligence (AI) can be used to improve the efficiency of cardiovascular care, ...

A study was conducted to determine the diagnostic performance of AI ECG interpretation for diagnosing STEMI. Artificial intelligence-based algorithms that utilize electrocardiogram data demonstrate ...

Detailed price information for Irhythm Holdings Inc (IRTC-Q) from The Globe and Mail including charting and trades.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...